Center for Pathology, Institute for Surgical Pathology
Breisacher Str. 115a
79106 Freiburg i. Brsg.
- +49 (0) 761/ 270 – 80230
- konrad.aumann@uniklinik-freiburg.de
- Homepage
Academic training
| 2000 - 2007 | Study of Medicine in Marburg and Würzburg, Germany |
Scientific qualifications
| 2017 | Habilitation in Experimental Medicine, University of Freiburg (Mentor: Prof. M. Wener) |
| 2008 | Dissertation in Medicine, University of Heidelberg (Supervisor: Prof. A. Greiner) |
Postgraduate Positions
| since 2018 | Consultant pathologist at the Institute for Surgical Pathology, Medical Center - University of Freiburg |
| 2011 - 2013 | Postdoctorate, Section of Molecular Hematology, Institute for Surgical Pathology, Medical Center - University of Freiburg |
| 2007 - 2018 | Assistant physician, Institute for Surgical Pathology, Medical Center - University of Freiburg |
Miscellaneous (Honours, Awards)
| 2012 | Fellowship of the Medical Faculty of the University of Freiburg |
| 2012 | Award of the 1. Nachwuchsakademie of the German Society of Pathology |
link to all publications from K. Aumann: Pubmed
Publications based on CRC1160 funding
Wu, Y., P. M. A. Zehnle, J. Rajak, N. Koleci, G. Andrieux, L. Gallego-Villar, K. Aumann, M. Boerries, C. M. Niemeyer, C. Flotho, S. Bohler, and M. Erlacher. 2023. BH3 mimetics and azacitidine show synergistic effects on juvenile myelomonocytic leukemia. Leukemia. doi:10.1038/s41375-023-02079-5.
Ruckert, T., G. Andrieux, M. Boerries, K. Hanke-Muller, N. M. Woessner, S. Doetsch, C. Schell, K. Aumann, J. Kolter, A. Schmitt-Graeff, M. Schiff, L. M. Braun, E. Haring, S. Kissel, B. A. Siranosian, A. S. Bhatt, P. Nordkild, J. Wehkamp, B. A. H. Jensen, S. Minguet, J. Duyster, R. Zeiser, and N. Kohler. 2022. Human beta-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling. Sci Transl Med 14: eabp9675. doi: 10.1126/scitranslmed.abp9675.
El Khawanky N, Hughes A, Yu W, Myburgh R, Matschulla T, Taromi S, Aumann K, Clarson J, Vinnakota JM, Shoumariyeh K, Miething C, Lopez AF, Brown MP, Duyster J, Hein L, Manz MG, Hughes TP, White DL, Yong ASM, Zeiser R. 2021. Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nat Commun. 12(1):6436. doi: 10.1038/s41467-021-26683-0.
Haring E, Andrieux G, Uhl FM, Krausz M, Proietti M, Sauer B, Esser PR, Martin SF, Pfeifer D, Schmitt-Graeff A, Duyster J, Köhler N, Grimbacher B, Boerries M, Aumann K, Zeiser R, Apostolova P. 2021. Therapeutic targeting of endoplasmic reticulum stress in acute graft-versus-host disease. Haematologica. doi: 10.3324/haematol.2021.278387.
Marschner, D., M. Falk, N. R. Javorniczky, K. Hanke-Muller, J. Rawluk, Schmitt-Graeff, F. Simonetta, E. Haring, S. Dicks, M. Ku, S. Duquesne, K. Aumann, D. Rafei-Shamsabadi, F. Meiss, P. Marschner, M. Boerries, R. S. Negrin, J. Duyster, R. Zeiser, and N. Kohler. 2020. MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors. JCI insight 5. pii: 132334. doi: 10.1172/jci.insight.132334.
